T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review)
- PMID: 39319215
- PMCID: PMC11421013
- DOI: 10.3892/ol.2024.14670
T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review)
Abstract
Gastric cancer (GC) remains a global healthcare challenge because of its high incidence and poor prognosis. The efficacy of current chemotherapy regimens for advanced GC is limited. T cells, which have been implicated in the progression of GC, have a significant impact in the tumor microenvironment. With a more detailed understanding of the mechanisms underlying the cancer immunoediting process, immunotherapy may become a promising treatment option for patients with GC. Several clinical trials are currently investigating different mechanisms targeting the tumor immune response. The present review summarized T cell-involved immune responses and various immunotherapy strategies for GC.
Keywords: gastric cancer; immune checkpoint inhibitors; immunoediting; immunotherapy; tumor immune microenvironment.
Copyright © 2024, Spandidos Publications.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis.J Transl Med. 2024 Aug 30;22(1):807. doi: 10.1186/s12967-024-05606-9. J Transl Med. 2024. PMID: 39215354 Free PMC article.
-
Immune evasion mechanisms and therapeutic strategies in gastric cancer.World J Gastrointest Oncol. 2022 Jan 15;14(1):216-229. doi: 10.4251/wjgo.v14.i1.216. World J Gastrointest Oncol. 2022. PMID: 35116112 Free PMC article. Review.
-
Recent advances in immune therapies for gastric cancer.Cancer Gene Ther. 2021 Sep;28(9):924-934. doi: 10.1038/s41417-021-00310-y. Epub 2021 Mar 4. Cancer Gene Ther. 2021. PMID: 33664460 Free PMC article. Review.
-
[Cancer Immunoediting in the Development of Cancer Immunotherapy].Gan To Kagaku Ryoho. 2019 Mar;46(3):407-411. Gan To Kagaku Ryoho. 2019. PMID: 30914573 Japanese.
-
Therapeutic strategies for gastric cancer targeting immune cells: Future directions.Front Immunol. 2022 Sep 23;13:992762. doi: 10.3389/fimmu.2022.992762. eCollection 2022. Front Immunol. 2022. PMID: 36225938 Free PMC article. Review.
Cited by
-
Advancements and challenges in immunotherapy for gastric cancer: current approaches and future directions.Front Immunol. 2025 May 21;16:1592733. doi: 10.3389/fimmu.2025.1592733. eCollection 2025. Front Immunol. 2025. PMID: 40469295 Free PMC article. Review.
-
Association Between Lymphocyte-High Density Lipoprotein Ratio and Cognitive Impairment in Chinese Older Adults: A Population-Based Cross-Section Study.Am J Alzheimers Dis Other Demen. 2025 Jan-Dec;40:15333175251361748. doi: 10.1177/15333175251361748. Epub 2025 Jul 30. Am J Alzheimers Dis Other Demen. 2025. PMID: 40736399 Free PMC article.
References
-
- Hundahl SA, Phillips JL, Menck HR. The national cancer data base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American joint committee on cancer staging, proximal disease, and the ‘different disease’ hypothesis. Cancer. 2000;88:921–932. doi: 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S. - DOI - PubMed
-
- Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–730. doi: 10.1056/NEJMoa010187. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous